IRYCIS Outstanding publication

• Tuesday, 5 May 2026

  de la Pinta C, Gamero V, Muriel A, Capuz AB, Moris R, Martin M, Alarza M, Montero A, Muñoz MT, Hernanz R, García ML, Sancho S.. Phase I study of stereotactic ablative radiotherapy (SABR) in inoperable breast cancer

  The Breast. 2026

  10.1016/j.breast.2026.104787

• Tuesday, 28 April 2026

  Fernández A, Subiela JD,..., Burgos FJ. Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups

  BJU Int. 2026

  10.1111/bju.70207

• Tuesday, 14 April 2026

  Fernández-de-Bobadilla, M.D., Pérez-Cobas, A.E., Andremont, A., Martínez, J.L., Baquero, F., Lanza, V.F.*, Coque, T.M*... The antimicrobial gut resistome of the Wayampi reveals a shared background of antibiotic and metal resistance genes with industrialized populations, underscoring the "robust-yet-fragile" architecture of human gut microbiomes

  Microbiome . 2026

  10.1186/s40168-026-02345-5

• Wednesday, 8 April 2026

  Moreno E, Caniego T, Ruz I, Carretero I, Cabezas E, Cortés A, Mendiola M, Redondo A, Muriel A, Hardisson D, Palacios J, Pérez-Mies B. MDM4 amplification as a potential predictor of risk of recurrence in early-stage low-grade endometrial carcinoma

  INT J GYNECOL CANCER. 2026

  10.1016/j.ijgc.2026.104563